Suchergebnisse - "Corso, Alessandro"

PubPharm (18)

1

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM) : outcomes by prior treatment at first relapse

enthalten in: Leukemia | 2021

von Dimopoulos, M. | Weisel, K. | Moreau, P. | +17

2

The association between insight and depressive symptoms in schizophrenia : Undirected and Bayesian network analyses

enthalten in: European psychiatry : the journal of the Association of European Psychiatrists | 2020

von Amore, M. | Murri, M. | Calcagno, P. | +80

3

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

enthalten in: British journal of haematology | 2020

von Montefusco, V. | Corso, A. | Galli, M. | +13

4

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Richardson, P. | Oriol, A. | Beksac, M. | +123

CommentIn: Lancet Oncol. 2019 Jun;20(6):743-744. - PMID 31097404

5

Management of infectious complications in multiple myeloma patients : Expert panel consensus-based recommendations

enthalten in: Blood reviews | 2019

von Girmenia, C. | Cavo, M. | Offidani, M. | +6

6

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3) : a double-blind, randomised, placebo-controlled phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Dimopoulos, M. | Gay, F. | Schjesvold, F. | +124

CommentIn: Lancet. 2019 Jan 19;393(10168):204-205. - PMID 30545778

7

Disorganization and real-world functioning in schizophrenia : Results from the multicenter study of the Italian Network for Research on Psychoses

enthalten in: Schizophrenia research | 2018

von Rocca, P. | Galderisi, S. | Rossi, A. | +91

8

Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Mohty, M. | Terpos, E. | Mateos, M. | +130

9

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

enthalten in: The New England journal of medicine | 2018

von Mateos, M. | Dimopoulos, M. | Cavo, M. | +127

10

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

enthalten in: Blood | 2017

von Oliva, L. | Orfanelli, U. | Resnati, M. | +16

CommentIn: Blood. 2017 Apr 13;129(15):2044-2045. - PMID 28408419